Repligen (RGEN) Earnings Date, Estimates & Call Transcripts $137.99 -1.44 (-1.03%) As of 04:00 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Repligen Earnings Summary Latest Q1 2025 Earnings DateApr. 29EstimatedConsensus EPS (Apr. 29) $0.35 Actual EPS (Apr. 29) $0.39 Beat By $0.04 Actual Revenue (Apr. 29) $169.17MRepligen issued Q1 2025 earnings on April 29, 2025, reporting an EPS of $0.39, which topped the consensus estimate of $0.35 by $0.04. Quarterly revenue rose 10.4% year-over-year to $169.17 million, above analysts' expectations of $163.65 million. With a trailing EPS of -$0.51, Repligen's earnings are expected to grow 37.21% next year, from $1.72 to $2.36 per share. Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Get Repligen Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Repligen and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataRGEN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RGEN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Repligen Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20253$0.32$0.44$0.37 Q2 20253$0.42$0.47$0.45 Q3 20253$0.42$0.46$0.43 Q4 20253$0.48$0.59$0.52 FY 202512$1.64$1.96$1.77 Q1 20262$0.48$0.65$0.57 Q2 20261$0.59$0.59$0.59 Q3 20261$0.59$0.59$0.59 Q4 20261$0.64$0.64$0.64 FY 20265$2.30$2.47 $2.39 Repligen Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails4/29/2025Q1 2025$0.35$0.39+$0.04$0.10$163.65M$169.17M2/20/2025Q4 2024$0.41$0.44+$0.03-$0.60$167.58M$167.55M11/12/2024Q3 2024$0.34$0.43+$0.09$0.87$153.34M$154.87M7/30/2024Q2 2024$0.33$0.33-$0.60$154.11M$154.07M5/1/2024Q1 2024$0.29$0.28 -$0.01$0.52$150.06M$151.31M2/21/2024Q4 2023$0.33$0.33-$1.12$155.38M$155.74M10/31/2023Q3 2023$0.14$0.23+$0.09$0.14$140.68M$141.20M8/2/2023Q2 2023$0.49$0.53+$0.04$0.71$165.93M$159.20M5/2/2023Q1 2023$0.59$0.64+$0.05$0.77$181.43M$182.70M Repligen Earnings - Frequently Asked Questions When did Repligen announce their last quarterly earnings? Repligen (NASDAQ:RGEN) last announced its quarterly earning data on Tuesday, April 29, 2025. Learn more on RGEN's earnings history. What guidance has Repligen issued on next quarter's earnings? Repligen updated its FY 2025 earnings guidance on Tuesday, April, 29th. The company provided EPS guidance of 1.630-1.720 for the period, compared to the consensus estimate of 1.710. The company issued revenue guidance of $695.0 million-$720.0 million, compared to the consensus revenue estimate of $700.8 million. Did Repligen beat their earnings estimates last quarter? In the previous quarter, Repligen (NASDAQ:RGEN) reported $0.39 earnings per share (EPS) to beat the analysts' consensus estimate of $0.35 by $0.04. Learn more on analysts' earnings estimate vs. RGEN's actual earnings. How much revenue does Repligen generate each year? Repligen (NASDAQ:RGEN) has a recorded annual revenue of $634.44 million. How much profit does Repligen generate each year? Repligen (NASDAQ:RGEN) has a recorded net income of $35.60 million. RGEN has generated -$0.51 earnings per share over the last four quarters. What is Repligen's price-to-earnings ratio? Repligen (NASDAQ:RGEN) has a forward price-to-earnings ratio of 79.58. The price/earnings-to-growth ratio is 4.54. What is Repligen's EPS forecast for next year? Repligen's earnings are expected to grow from $1.72 per share to $2.36 per share in the next year, which is a 37.21% increase. More Earnings Resources from MarketBeat Related Companies Biogen Earnings Date United Therapeutics Earnings Date BioMarin Pharmaceutical Earnings Date Incyte Earnings Date Exelixis Earnings Date Neurocrine Biosciences Earnings Date Exact Sciences Earnings Date Halozyme Therapeutics Earnings Date Madrigal Pharmaceuticals Earnings Date Ionis Pharmaceuticals Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings Will Make or Break the Stock's Comeback CrowdStrike Stock Nears Record High, Dip Ahead of Earnings?Alphabet Rebounds After Strong Earnings and Buyback AnnouncementMarkets Think Robinhood Earnings Could Send the Stock UpIs the Floor in for Lam Research After Bullish Earnings?Texas Instruments: Earnings Beat, Upbeat Guidance Fuel RecoveryMarket Anticipation Builds: Joby Stock Climbs Ahead of Earnings This page (NASDAQ:RGEN) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repligen Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repligen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RGEN Stock Free RGEN Stock Alerts